Combination of apatinib mesylate and second-line chemotherapy for treating gastroesophageal junction adenocarcinoma
Author:
Affiliation:
1. Oncology, Yangzhong People’s Hospital, Yangzhong, China
2. Oncology, Yangzhong Cancer Institute, Yangzhong, China
3. Nanjing University of Chinese Medicine, Nanjing, China
Abstract
Funder
National TCM Clinical Research Base for Business Research and Special Projects
Jiangsu Province Blue Project
National Natural Science Foundation of China
Publisher
SAGE Publications
Subject
Biochemistry (medical),Cell Biology,Biochemistry,General Medicine
Link
http://journals.sagepub.com/doi/pdf/10.1177/0300060519827191
Reference20 articles.
1. Tumor Stage After Neoadjuvant Chemotherapy Determines Survival After Surgery for Adenocarcinoma of the Esophagus and Esophagogastric Junction
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Safety and Efficacy of of apatinib combined with chemotherapy in the second-line and subsequent lines of advanced gastric cancer: A systematic review and meta-analysis;2023-12-13
2. Expression of p53 as a biomarker in determining response to apatinib for advanced gastric cancer;Frontiers in Oncology;2023-08-15
3. Advances in targeted therapy and immunotherapy for esophageal cancer;Chinese Medical Journal;2023-07-05
4. SN‐38, an active metabolite of irinotecan, enhances anti‐PD‐1 treatment efficacy in head and neck squamous cell carcinoma;The Journal of Pathology;2023-02-24
5. Efficacy and safety of intermittent versus continuous dose apatinib plus docetaxel as second-line therapy in patients with advanced gastric cancer or gastroesophageal junction adenocarcinoma: a randomized controlled study;Annals of Translational Medicine;2022-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3